Professional Documents
Culture Documents
(ASD), is crucial for integration into early intervention as this is a key prognostic indicator for
optimising positive outcomes (Levy & Perry, 2011; Nowell et al., 2015). A crucial limitation
though, is the delay or failure in identifying the disorder in early childhood. ASD is a
behaviours (American Psychiatric Association [APA], 2013). In 2013, the DSM-5 combined
single disorder, yet, on a wide ‘spectrum’ (APA, 2013; Park et al., 2016). To meet diagnostic
criteria, there must be persistent functional impairment in social communication and social
In the past decade, prevalence rates have almost doubled. According to the World
Australians are living with ASD (Australian Bureau Statistics, 2018). The Centre for Disease
Control and Prevention (CDC) reveal ASD is four times more common in males, though, the
exact cause remains unknown as currently there is no medical test to diagnose. The increase
in prevalence is thought to be, at least partially, due to the DSM-IV broadening the definition
of ASD and therefore increasing the opportunity for many cases to be identified that would
Consequently, as prevalence has increased, so has the need for valid, efficient, and
effective standardised screening measures. Despite the ability to reliably diagnose ASD as
early as 24 months, the median age of diagnosis is generally delayed until 48, 53, and 78
months (CDC, 2016). Two primary sources of information are typically employed when
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
with measuring development in childhood (Thabtah & Peebles, 2019). For example, Robins
et al., (2014) claims utilising a parent-screening tool at population level would help identify a
larger pool of children at-risk of ASD or other developmental disorders and therefore
reducing the gap to much needed early intervention. In contrast, Fein & Baby Sibs Research
Consortium, (2016) claims parent-report screening tools at population level may be highly
bias and would produce too many false positives. Trained clinician screening is needed as
the potential effect of subjecting children to ASD treatment when they do not have the
To address concerns with both approaches, efforts to determine the most effective
instruments utilised (Matson et al., 2007). Validity and reliability are considered the central
measures what it intends to measures and reliability refers to the extent to which an
instrument produces consistent results that could be replicated and generalised (Matson et
al., 2007).
analyse and compare the evidence for a screening parent-report; Modified Checklist for
Screening Tool for Autism in Toddlers and Young Children (STAT). The psychometrics
properties of each tool will be discussed and any cultural and ethical considerations will be
explored. Given the brevity and significance in which an early ASD diagnosis is most
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
between the ages of 18 and 24 months and suggests the universal practice is optional to
reduce the age of diagnosis for ASD (CDC, 2016). Currently, there are two levels of ASD
screening; level 1: intended for the ‘unselected’, to help identify any developmental
disorders in the general population, and level 2: intended for children at increased risk for
ASD either from familial predisposition, genetic risk factors, or from demonstrating
The Modified Checklist for Autism in Toddlers, Revised, with Follow-Up (M-CHAT-R/F):
parent-report questionnaire checklist, designed to assess the risk of ASD in children aged 16
and 30 months. For the initial stage, the parents complete a binary 20-item questionnaire to
help determine the child’s current behaviours using a yes/no format. In approximately 5-10
minutes, parents can answer and complete domain specific questions regarding; pretend
play, following a point, pretending, producing a point, and proto-declarative pointing, and
receive a score to see if further assessment is necessary (Weitlauf et al., 2015). Three items
are reversed scored, three are distractor items, and all items were reorganised in the
modified version to reduce bias. Scores between the moderate-risk range of 3-7 means a
follow-up interview (FUI) is needed with a professional to gather further information (second
stage). If score remains at two or higher at FUI, the child has screened positive. Higher
scores are indicative of more ASD-related concerns with 8-20 indicating a FUI can be
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
bypassed, instead, it is recommended to refer the child for a diagnostic evaluation (Robins et
al., (2014)
The Screening Tool for Autism in Toddlers and Young Children (STAT):
screening tool to identify toddlers between the ages of 24 and 36 months. The tool assesses
behaviours in the areas of early social and communicative behaviours including: play,
administer (Stone et al., 2004). The tool consists of 12-items that are derived from three
measures: the Motor Imitation Scale, the Play Assessment Scale, and the Prelinguistic
Communication Assessment (Stone et al., 2004). The STAT consists of four imitation items,
four directing attention items, two play items, and two requesting items for facilitating
interaction. However, the two requesting items are not included in the scoring system. Each
item is scored as a pass or fail, and the number of passes in each area is summed to obtain
an area score (Stones et al., 2000). It is noted, because the domains contain an unequal
number of items, equal weighting is achieved by expressing domain scores as the proportion
of failed items to total items (i.e., domain with two items can be 0, .5, or 1) . The total score
is achieved by summing the four domain scores and can range from 0 to 4, with higher
identify when a disorder is present, specificity; how well a test identifies those who do not
have the disease, positive predictive value (PPV); the probability that children with a positive
screening have the disorder, and negative predictive value (NPV); the probability that
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
children with a negative screening truly do not have the disease (Parikh et al., 2008; Thabtah
& Peebles, 2019). An adequate balance between sensitivity and specificity is ideal, though,
sensitivity is noted as the most salient for early ASD screeners (Barton et al., 2012).
regarding a child’s development and behaviour. The history of a child and observations in a
naturalistic setting is information that could otherwise not be measured in a clinical setting
(Nordahl-Hansen et al., 2014). The M-CHAT-R/F is currently one of the most worldwide used
children with ASD as possible, while also significantly reducing false positives rates, the
M-CHAT was revised from its initial 23 questions to 20 questions and a second follow-up
longitude study with a sample of 16,071 low-risk toddlers in the United States. To determine
optimal cut-off scores, Receiver Operator Characteristic (ROC) analysis was applied to
establish the score >3 as ideal. At the initial stage, sensitivity and specificity were high .911
and .955, however, at FUI sensitivity decreased and specificity increased .833 and .992
respectively. The tool had excellent criterion validity (the degree to which the measure
correlates with a gold-standard measure), yet, across all items, internal consistency was poor
(α = .63). Considering the items do not assess a unitary dimension, motor items were
created to be distractors, and Cronbach Alpha was calculated as a total scale instead of each
threshold. Among those who had positive-screening in both the first stage (18 months) and
FUI (24 months), 47% (PPV) had a risk of being diagnosed with ASD (95% CI: 0.41–0.54) and
a 94.6% risk for developmental delay concerns (95% CI: 0.92–0.98). Though, this could be
interpreted as the tool screening more broadly than just for ASD, although, given the
unknown sensitivity for such purposes it cannot be justified. When compared with published
studies using the previous version in low-risk samples, there is a significant reduction in the
initial screen-positive rate (from 9.15% to 7.17% p < .001). This implies the tool is successful
as fewer children required a FUI, the rate of detection had significantly increased, while also
maintaining high sensitivity (Chlebowski et al., 2013; Robins et al., 2001). It is not certain
however, if the increase in detection is due to increased ASD prevalence or from improved
effective screening tool in low risk children under the age of 36 months. A Bayesian model
which is established as a strong method of analysis, was used to estimate the screening
specificity 0.98 (95% CI). However only 66.6% of the studies showed all the primary
evidence for the tool being effective for identifying ASD in low risk children aged between 18
to 24. Though, considering the authors aim was to assess the M-CHAT-R/F as a universal
screening tool for ASD, there was only one low risk study, and PPV was calculated for only
high risk studies 0.53 (95% CI: 0.43–0.63), possibly suggesting selection bias. Additionally,
studies have found at the initial 18 month screen, only about a third of children were
identified of the cases ultimately recognised, in younger low risk toddlers PPV was lower
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
(0.28) compared to older (0.61), ASD symptoms were more likely to emerge gradually,
hence, more noticeable after 18 months ( i.e., repetitive behaviours), and many high risk
siblings not diagnosed at 18 months were eventually diagnosed at 36 months revealing poor
sensitivity and increased false negatives (Chlebowski et al., 2013; Ozonoff et al., 2015;
Robins et al., 2014; Stenberg et al., 2014; Sturner et al., 2013). These findings suggest that
18 months old’s who do not score high enough for FUI should still be monitored.
Despite the low-cost and feasibility of the M-CHAT-R/F, concerns have been raised
milestones and likely to attend to unusual or challenging behaviours (Zapolski & Smith,
2013). In addition, report and recall bias is likely to occur as parents perception of a child’s
developmental delays (Ozonoff et al., 2015). On the contrary, trained clinicians are expected
to offer an unbiased, objective, and standardised assessment. Interactive screening tools like
the STAT have the advantage of providing clinicians with the opportunity to detect any subtle
So far, the STAT is the only level 2 screener comprised of interactive items and
numerous studies have revealed strong psychometric properties. For instance, in an attempt
to screen for Autism in children aged 24 to 36 months, Stones et al., (2004) provided the
STAT to fifty-two participants; toddlers clinically diagnosed with autism (n = 26) and
developmental delay and/or language impairment (DD/LI) (n = 26). The authors went to
great measures to validate the screening tool. In study 1, matched pairs were used to
establish the optimal cut-off of 2 and as a result the STAT had high sensitivity 0.92, specificity
0.85, PPV 0.86, and NPV 0.92, indicating a respectable rate for identifying children with or
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
without a clinical autism diagnosis. In study 2, children with a clinical autism diagnosis (n =
50), PDD-NOS (n = 15), and DD/LI (n = 39) were evaluated by administers blind to referral or
diagnosis. Using Cohen’s Kappa; STAT risk interrater agreement was 1.00 an almost perfect
agreement, STAT risk test-retest reliability was 0.90, and concurrent validity comparing STAT
with Autism Diagnostic Observation Schedule-Generic (ADOS-G) was high 0.95. Although the
STAT demonstrated high PPV in identifying children at risk for autism, it was less accurate at
identifying PDD-NOS and other milder ASD symptoms. This could be a potential issue
considering the DSM-5 modified the diagnosis of autism to a spectrum with milder
symptoms .
In their subsequent study using the STAT in children younger than 24 months,
children with PDD-NOS were included. However, the non-ASD sample contained a high
number of children with siblings already diagnosed with ASD (Stones et al., 2008). It is not
clear though if administers were blind to this information so clinician bias needs to be
substantially better specificity 0.83 and PPV 0.68. Although the PPV at a young age needs to
be considered when evaluating ASD screening instruments, the average lag in this study
between screen and diagnosis was 15 months (Stones et al., 2008). Hence, based on the
screening information provided, it is still unclear if a child will continue to meet diagnostic
criteria or severity of symptoms (Brewer et al., 2020). The clinical-setting, small sample size,
and outcome diagnosis of ASD (n = 19) needs to be acknowledged as a limitation for future
replication.
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
Most of the documented knowledge of prevalence and interventions has come from
services (Canal-Bedia et al., 2011; Koh et al., 2014; Nygren et al., 2012). However, studies
have confirmed ASD is not limited to affluent, English-speaking countries (Samadi &
McConkey, 2011). Mandell, Novak, and Zubritsky (2005) found diagnosis of ASD on average,
is 11 months later for those in low income families, low parental education, and from
ethnic/race minority. Differences in prevalence are associated with factors such as limited
access to healthcare, stigma, and cultural differences in behaviours for ASD diagnosis. For
example, the M-CHAT-R/F considers limited eye contact as an ASD characteristic, however,
countries like Japan and Ghana consider this as a sign of respect (Akechi et al., 2013).
Therefore it is vital to examine the validity and reliability of the M-CHAT-R/F and STAT in
The M-CHAT-R/F has been translated into over 50 languages and the modification to
use illustrations and simple language is suggested to improve comprehension in both English
and non-English speaking languages when translated (Robins et al., 2014). The M-CHAT-R/F
has been successful across countries such as Albania, Serbia, Indonesia, China, and West
Africa. Recording high sensitivity and specificity (Brennan et al., 2016; Carakovac et al., 2016;
Guo et al., 2019; Petrocchi et al., 2020). However several concerns need to be considered
when it comes to psychological test and the conduct of assessment for cultural differences.
First, pilot-testing of the translated M-CHAT-R/F is needed to strengthen both semantic and
content equivalence (AI Maskari et al., 2018). A longitudinal Chinese study by Guo et al.,
(2019) found the M-CHAT-R/F was successful in differentiating children at risk of ASD from
developmental delays, however, no pilot test was conducted, possibly affecting research
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
findings. Further, an Albanian study by Brennan et al., (2016) found the M-CHAT-R/F has the
items such as the three reverse-scored sensory symptom items (have you ever wondered if
your child was deaf?, does your child make unusual finger movements near their eyes?, does
your child get upset by everyday noises?) were removed. As a result, internal consistency at
the initial stage increased from (α = .737) to (α = .886), follow up remained stable (α = .931),
and out of all the children screened, 9.75% screened positive (PPV 0.16), and at follow-up,
Second, cultural background may influence attitudes and knowledge of ASD which
can influence willingness to interact (Samadi & McConkey, 2011). Several studies have found
attrition rates were higher in those of race/ethnic minorities and low parental education and
SES. The M-CHAT-R/F has the advantage of being able to screen from home (private setting)
without fear of stigma while also providing information of ASD symptoms. However, this is
only beneficial if the parent has knowledge and awareness of abnormal developmental
trained professionals with knowledge of ASD symptoms that parents may not have. However
this would need valid consent from the parent to be ethical, which may be a barrier in some
cultures that fear stigmatisation (cite). Furthermore, children may be reluctant to talk to an
adult, especially from a cultural group. Hence, the clinician’s cultural perspective and biases
Discussion:
Screening tools are a vital for the early identification of ASD. Numerous studies have
revealed early interventions are correlated with optimal outcomes in children with ASD
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
(Levy & Perry, 2011; Nowell et al., 2015). Two primary approaches to screening tools are
currently utilised; level 1 for the general population level and level 2 for children already
questionnaire that be used to assess risk of ASD (Petrocchi et al., 2020; Stone et al., 2004).
The STAT is a clinician-administered screening tool for referred children. Both tools have
advantages and disadvantages. For example, both the M-CHAT-R/F and STAT have
demonstrated strong psychometric properties with adequate sensitivity, specificity, and PPV
in nearly all studies (Robins et al., 2014). The modified M-CHAT-R/F has two stages and is
able to detect more screen-positives with the second stage beneficial for identifying any
parents answers are through their perspectives (Ozonoff et al., 2015). Alternatively, the STAT
is considered to be an unbiased and objective screening tool with the advantage of having a
trained clinician to pick up on abnormal social and behavioural problems parents may
Based on the evidence, the M-CHAT-R/F and its two stage parent-report and FUI is
the chosen preferred screening method. The two stages not only allows early detection, it
also offers a FUI to gain more information for an accurate diagnosis. The M-CHAT-R/F is
cost-effective and feasible and therefore beneficial to low SES and race/ethnic minorities
who may be limited to healthcare. Furthermore, the tool can be translated into over 50
languages making to accessible to those where English is not the first language. Finally, the
M-CHAT-R/F can be used in a natural setting to screen and gather information on symptoms
References:
Al Maskari, T. S., Melville, C. A., & Willis, D. S. (2018). Systematic review: cultural
adaptation and feasibility of screening for autism in non-English speaking
countries. International journal of mental health systems, 12, 22.
https://doi.org/10.1186/s13033-018-0200-8
Akechi, H., Senju, A., Uibo, H., Kikuchi, Y., Hasegawa, T., & Hietanen, J. K. (2013).
Attention to eye contact in the West and East: autonomic responses and evaluative
ratings. PloS one, 8(3), e59312. https://doi.org/10.1371/journal.pone.0059312
Australian Bureau of Statistics. (2018). Disability, Ageing and Careres, Australia: Sumaary
of Findings. (Cat. No. 4430.0) Retrieved from
https://www.abs.gov.au/statistics/health/disability/disability-ageing-and-carers-australia-su
mmary-findings/latest-release#autism-in-australia
Barton, M. L., Barton, M. L., Dumont-Mathieu, T., Dumont-Mathieu, T., Fein, D., & Fein, D.
(2012). Screening young children for autism spectrum disorders in primary practice. Journal
of Autism and Developmental Disorders, 42(6),
1165-1174. https://doi.org/10.1007/s10803-011-1343-5
Biggi, J., Posada-de la Paz, M., & Posada-de la Paz, M. (2011). Modified checklist for
autism in toddlers: Cross-cultural adaptation and validation in spain. Journal of Autism and
Developmental Disorders, 41(10), 1342-1351. https://doi.org/10.1007/s10803-010-1163-z
Bonis, S. (2016). Stress and parents of children with autism: A review of literature. Issues
in Mental Health Nursing, 37(3), 153-163. https://doi.org/10.3109/01612840.2015.1116030
Brennan, L., Fein, D., Como, A., Rathwell, I. C., & Chen, C. (2016). Use of the modified
checklist for autism, revised with follow up-albanian to screen for ASD in albania. Journal of
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
Brewer, N., Young, R. L., & Lucas, C. A. (2020). Autism Screening in Early Childhood:
Discriminating Autism From Other Developmental Concerns. Frontiers in neurology, 11,
594381. https://doi.org/10.3389/fneur.2020.594381
Canal-Bedia, R., Canal-Bedia, R., García-Primo, P., García-Primo, P., Martín-Cilleros, M. V.,
Martín-Cilleros, M. V., Santos-Borbujo, J., Santos-Borbujo, J., Guisuraga-Fernández, Z.,
Guisuraga-Fernández, Z., Herráez-García, L., Herráez-García, L., del Mar Herráez-García, M.,
del Mar Herráez-García, M., Boada-Muñoz, L., Boada-Muñoz, L., Fuentes-Biggi, J., Fuentes-
Carakovac, M., Jovanovic, J., Kalanj, M., Rudic, N., Aleksic-Hil, O., Aleksic, B., Villalobos, I.
B., Kasuya, H., Ozaki, N., Lecic-Tosevski, D., & Pejovic-Milovancevic, M. (2016). Serbian
language version of the modified checklist for autism in toddlers, revised, with follow-up:
Cross-cultural adaptation and assessment of reliability. Scientific Reports, 6(1),
38222-38222. https://doi.org/10.1038/srep38222
Centres for Disease Control and Prevention. (2016). Autism Spectrum Disorder: Data and
Statistics, United States of America. Retrieved from:
https://www.cdc.gov/ncbddd/autism/data.html
Chlebowski, C., Robins, D. L., Barton, M. L., & Fein, D. (2013). Large-scale use of the
modified checklist for autism in low-risk toddlers. Pediatrics, 131(4), e1121–e1127.
https://doi.org/10.1542/peds.2012-1525
Chiri, G., Chiri, G., Warfield, M. E., & Warfield, M. E. (2012). Unmet need and
problems accessing core health care services for children with autism spectrum disorder.
Maternal and Child Health Journal, 16(5), 1081-1091.
https://doi.org/10.1007/s10995-011-0833-6
Dawson, G., & Bernier, R. (2013). A quarter century of progress on the early detection
and treatment of autism spectrum disorder. Development and Psychopathology, 25(4 Pt 2),
1455-1472. https://doi.org/10.1017/S0954579413000710
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
Ennis-Cole, D., Durodoye, B. A., & Harris, H. L. (2013). The impact of culture on autism
diagnosis and treatment: Considerations for counselors and other professionals. The Family
Journal (Alexandria, Va.), 21(3), 279-287. https://doi.org/10.1177/1066480713476834
Falkmer, T., Anderson, K., Falkmer, M., & Horlin, C. (2013). Diagnostic procedures in
autism spectrum disorders: A systematic literature review. European Child & Adolescent
Psychiatry, 22(6), 329-340. https://doi.org/10.1007/s00787-013-0375-0
Fein, D., & Baby Sibs Research Consortium (2016). Commentary on USPSTF Final
Statement on Universal Screening for Autism. Journal of developmental and behavioral
pediatrics : JDBP, 37(7), 573–578. https://doi.org/10.1097/DBP.0000000000000345
Guo, C., Guo, C., Luo, M., Luo, M., Wang, X., Wang, X., Huang, S., Huang, S., Meng, Z.,
Meng, Z., Shao, J., Shao, J., Zhang, X., Zhang, X., Shao, Z., Shao, Z., Wu, J., Wu, J., Robins, D.
L., . . . Jing, J. (2019). Reliability and validity of the chinese version of modified checklist for
autism in toddlers, revised, with follow-up (M-CHAT-R/F). Journal of Autism and
Developmental Disorders, 49(1), 185-196. https://doi.org/10.1007/s10803-018-3682-y
Kamio, Y., Haraguchi, H., Stickley, A., Ogino, K., Ishitobi, M., & Takahashi, H. (2015). Brief
report: Best discriminators for identifying children with autism spectrum disorder at an
18-month health check-up in japan. Journal of Autism and Developmental Disorders, 45(12),
4147-4153. https://doi.org/10.1007/s10803-015-2527-1
Koh, H. C., Koh, H. C., Lim, S. H., Lim, S. H., Chan, G. J., Chan, G. J., Lin, M. B., Lin, M. B.,
Lim, H. H., Lim, H. H., Choo, S. H. T., Choo, S. H. T., Magiati, I., & Magiati, I. (2014). The clinical
utility of the modified checklist for autism in toddlers with high risk 18–48 Month old
children in singapore. Journal of Autism and Developmental Disorders, 44(2),
405-416. https://doi.org/10.1007/s10803-013-1880-1
Levy, A., & Perry, A. (2011). Outcomes in adolescents and adults with autism: A review of
the literature. Research in Autism Spectrum Disorders, 5(4), 1271-1282.
doi:10.1016/j.rasd.2011.01.023
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
Mandell, D. S., Morales, K. H., Xie, M., Lawer, L. J., Stahmer, A. C., & Marcus, S. C.
(2010). Age of diagnosis among medicaid-enrolled children with autism, 2001-2004.
Psychiatric Services (Washington, D.C.), 61(8), 822.
Mandell, D. S., Novak, M. M., & Zubritsky, C. D. (2005). Factors associated with age of
diagnosis among children with autism spectrum disorders. Pediatrics, 116(6), 1480–1486.
https://doi.org/10.1542/peds.2005-0185
Mazefsky, C. A., Kao, J., & Oswald, D. P. (2011). Preliminary evidence suggesting
caution in the use of psychiatric self-report measures with adolescents with high-functioning
autism spectrum disorders. Research in Autism Spectrum Disorders, 5(1), 164-174.
https://doi.org/10.1016/j.rasd.2010.03.006
Miller, L. E., Perkins, K. A., Dai, Y. G., & Fein, D. A. (2017). Comparison of parent
report and direct assessment of child skills in toddlers. Research in Autism Spectrum
Disorders, 41-42, 57-65. https://doi.org/10.1016/j.rasd.2017.08.002
Nowell, K. P., Brewton, C. M., Allain, E., & Mire, S. S. (2015). The influence of
demographic factors on the identification of autism spectrum disorder: A review and call for
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
Nygren, G., Sandberg, E., Gillstedt, F., Ekeroth, G., Arvidsson, T., Gillberg, C., Gillberg
Neuropsychiatry Centre, Sahlgrenska akademin, Göteborgs universitet, Gothenburg
University, Gillbergcentrum, & Sahlgrenska Academy. (2012). A new screening programme
for autism in a general population of swedish toddlers. Research in Developmental
Disabilities, 33(4), 1200-1210. https://doi.org/10.1016/j.ridd.2012.02.018
Ozonoff, S., Young, G. S., Landa, R. J., Brian, J., Bryson, S., Charman, T., Chawarska, K.,
Macari, S. L., Messinger, D., Stone, W. L., Zwaigenbaum, L., & Iosif, A. (2015). Diagnostic
stability in young children at risk for autism spectrum disorder: A baby siblings research
consortium study. Journal of Child Psychology and Psychiatry, 56(9),
988-998. https://doi.org/10.1111/jcpp.12421
Parikh, R., Mathai, A., Parikh, S., Chandra Sekhar, G., & Thomas, R. (2008).
Understanding and using sensitivity, specificity and predictive values. Indian Journal of
Ophthalmology, 56(1), 45-50. https://doi.org/10.4103/0301-4738.37595
Park, H. R., Lee, J. M., Moon, H. E., Lee, D. S., Kim, B. N., Kim, J., Kim, D. G., & Paek, S.
H. (2016). A Short Review on the Current Understanding of Autism Spectrum Disorders.
Experimental neurobiology, 25(1), 1–13. https://doi.org/10.5607/en.2016.25.1.1
Payakachat, N., Tilford, J. M., Kovacs, E., & Kuhlthau, K. (2012). Autism spectrum
disorders: a review of measures for clinical, health services and cost-effectiveness
applications. Expert review of pharmacoeconomics & outcomes research, 12(4), 485–503.
https://doi.org/10.1586/erp.12.29
Petrocchi, S., Levante, A., & Lecciso, F. (2020). Systematic review of level 1 and level 2
screening tools for autism spectrum disorders in toddlers. Brain Sciences, 10(3),
180. https://doi.org/10.3390/brainsci10030180
Prior, M., & Roberts, J.M.A. (2012). A review of the research to identify the most
effective models of practice in early intervention for children with autism spectrum
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
Robins, D. L., Casagrande, K., Barton, M., Chen, C. M., Dumont-Mathieu, T., & Fein, D.
(2014). Validation of the modified checklist for Autism in toddlers, revised with follow-up
(M-CHAT-R/F). Pediatrics, 133(1), 37–45. https://doi.org/10.1542/peds.2013-1813
Samadi, S. A., & McConkey, R. (2011). Autism in developing countries: lessons from
iran. Autism research and treatment, 2011, 145359. https://doi.org/10.1155/2011/145359
Siklos, S., & Kerns, K. A. (2007). Assessing the diagnostic experiences of a small sample of
parents of children with autism spectrum disorders. Research in Developmental Disabilities,
28(1), 9-22. https://doi.org/10.1016/j.ridd.2005.09.003
Stenberg, N., Bresnahan, M., Gunnes, N., Hirtz, D., Hornig, M., Lie, K. K., Lipkin, W. I.,
Lord, C., Magnus, P., Reichborn-Kjennerud, T., Schjølberg, S., Surén, P., Susser, E., Svendsen,
B. K., von Tetzchner, S., Øyen, A., & Stoltenberg, C. (2014). Identifying children with autism
spectrum disorder at 18 months in a general population sample: Identifying children with
ASD at 18 months. Paediatric and Perinatal Epidemiology, 28(3),
255-262. https://doi.org/10.1111/ppe.12114
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
Stone, W. L., Coonrod, E. E., & Ousley, O. Y. (2000). Brief report: Screening tool for autism
in two-year-olds (STAT): Development and preliminary data. Journal of Autism and
Developmental Disorders, 30(6), 607-612. https://doi.org/10.1023/A:1005647629002
Stone, W. L., Coonrod, E. E., Turner, L. M., & Pozdol, S. L. (2004). Psychometric properties
of the STAT for early autism screening. Journal of Autism and Developmental
Disorders, 34(6), 691-701. https://doi.org/10.1007/s10803-004-5289-8
Sturner, R., Howard, B., Bergmann, P., Morrel, T., Landa, R., Walton, K., & Marks, D.
(2017). Accurate autism screening at the 18-month well-child visit requires different
strategies than at 24 months. Journal of Autism and Developmental Disorders, 47(10),
3296-3310. https://doi.org/10.1007/s10803-017-3231-0
Stone, W. L., McMahon, C. R., & Henderson, L. M. (2008). Use of the screening tool for
autism in two-year-olds (STAT) for children under 24 months: An exploratory study. Autism :
The International Journal of Research and Practice, 12(5),
557-573. https://doi.org/10.1177/1362361308096403
Taylor, L. J., Eapen, V., Maybery, M. T., Midford, S., Paynter, J., Quarmby, L., Smith, T.,
Williams, K., & Whitehouse, A. J. O. (2016). Diagnostic evaluation for autism spectrum
disorder: A survey of health professionals in australia. BMJ Open, 6(9), e012517-e012517.
https://doi.org/10.1136/bmjopen-2016-012517
Tsai, J., Lu, L., Jeng, S., Cheong, P., Gau, S. S., Huang, Y., & Wu, Y. (2019). Validation of
the modified checklist for autism in toddlers, revised with follow-up in taiwanese
toddlers. Research in Developmental Disabilities, 85,
205-216. https://doi.org/10.1016/j.ridd.2018.11.011
A COMPARISON OF STANDARDISED SCREENING MEASURES IN ASD
Vivanti, G., Prior, M., Williams, K., & Dissanayake, C. (2014). Predictors of outcomes in
autism early intervention: Why don't we know more? Frontiers in Pediatrics, 2, 58-58.
https://doi.org/10.3389/fped.2014.00058
Weitlauf, A. S., Vehorn, A. C., Stone, W. L., Fein, D., & Warren, Z. E. (2015). Using the
M-CHAT-R/F to identify developmental concerns in a high-risk 18-month-old sibling
sample. Journal of Developmental and Behavioral Pediatrics, 36(7), 497.
Yuen, T., Penner, M., Carter, M. T., Szatmari, P., & Ungar, W. J. (2018). Assessing the
accuracy of the modified checklist for autism in toddlers: A systematic review and
meta‐analysis. Developmental Medicine and Child Neurology, 60(11),
1093-1100. https://doi.org/10.1111/dmcn.13964
Zapolski, T. C. B., & Smith, G. T. (2013). Comparison of parent versus child-report of child
impulsivity traits and prediction of outcome variables. Journal of Psychopathology and
Behavioral Assessment, 35(3), 301-313. https://doi.org/10.1007/s10862-013-9349-2
Zeleke, W. A., Hughes, T. L., & Drozda, N. (2019). Disparities in diagnosis and service
access for minority children with ASD in the united states. Journal of Autism and
Developmental Disorders, 49(10), 4320-4331. https://doi.org/10.1007/s10803-019-04131-9